MedPath

Omegaven

These highlights do not include all the information needed to use OMEGAVEN safely and effectively. See full prescribing information for OMEGAVEN. OMEGAVEN (fish oil triglycerides) injectable emulsion, for intravenous useInitial U.S. Approval: 2018

Approved
Approval ID

5d9d0b24-e139-48bf-ab2d-536fb59cf8e0

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 19, 2023

Manufacturers
FDA

Fresenius Kabi USA, LLC

DUNS: 608775388

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fish oil

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63323-205
Application NumberNDA210589
Product Classification
M
Marketing Category
C73594
G
Generic Name
Fish oil
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJuly 19, 2023
FDA Product Classification

INGREDIENTS (7)

glycerinInactive
Code: PDC6A3C0OX
Classification: IACT
sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT
Fish oilActive
Quantity: 0.1 g in 1 mL
Code: XGF7L72M0F
Classification: ACTIB
.alpha.-tocopherol, dl-Inactive
Code: 7QWA1RIO01
Classification: IACT
egg phospholipidsInactive
Code: 1Z74184RGV
Classification: IACT
sodium oleateInactive
Code: 399SL044HN
Classification: IACT
waterInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Omegaven - FDA Drug Approval Details